EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic Value of Anti-HTLV-1-Antibody Quantification in Cerebrospinal Fluid for HTLV-1-Associated Myelopathy

Tomoo Sato, Naoko Yagishita, Natsumi Araya, Makoto Nakashima, Erika Horibe, Katsunori Takahashi, Yasuo Kunitomo, Yukino Nawa, Isao Hamaguchi, Yoshihisa Yamano

Viruses · 2024

DOI: 10.3390/v16101581 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Tomoo Sato und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki 216-8512, Japan. Hauptthemen laut MEDLINE: Paraparesis, Tropical Spastic, Human T-lymphotropic virus 1, Sensitivity and Specificity. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health and Labour Sciences Research Grant on Rare and Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan, Practical Research Project for Rare/Intractable Diseases of the Japan Agency for Medical Research and Development, Ministry of Health, Labour, and Welfare of Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The diagnostic accuracy of cerebrospinal fluid (CSF) anti-human T-cell leukemia virus type I (HTLV-1) antibody testing for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM) remains unclear. Therefore, we measured the anti-HTLV-1 antibody levels in CSF using various test kits, evaluated the stability of CSF antibodies, and performed a correlation analysis using the particle agglutination (PA) method, as well as a receiver operating characteristic (ROC) analysis between patients with HAM and carriers. The CSF anti-HTLV-1 antibody levels were influenced by freeze–thaw cycles but remained stable when the CSF was refrigerated at 4 °C for up to 48 h. Measurements from 92 patients (69 patients with HAM and 23 carriers) demonstrated a strong correlation (r > 0.9) with the PA method across all six quantifiable test kits. All six test kits, along with CSF neopterin and CXCL10, exhibited areas under the ROC curve greater than 0.9, indicating a high diagnostic performance for HAM. Among these, five test kits, Lumipulse and Lumipulse Presto HTLV-I/II, HISCL-UD (a kit under development), HTLV-Abbott, and Elecsys HTLV-I/II, established a cutoff with 100% sensitivity and maximum specificity, achieving a sensitivity of 100% and a specificity ranging from 43.5% to 56.5%. This cutoff value, in combination with clinical findings, will aid in the accurate diagnosis of HAM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Paraparesis, Tropical SpasticHuman T-lymphotropic virus 1Sensitivity and SpecificityHumansMaleFemaleMiddle AgedAdultAgedHTLV-I AntibodiesROC CurveHTLV-I InfectionsReagent Kits, DiagnosticNeopterinChemokine CXCL10

Stichwörter der Autor:innen

HTLV-1-associated myelopathyanti-HTLV-1 antibodycerebrospinal fluiddiagnosishuman T-cell leukemia virus type 1

Substanzen

HTLV-I AntibodiesReagent Kits, DiagnosticNeopterinChemokine CXCL10

Autor:innen und Institutionen

  • Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki 216-8512, Japan.
  • Department of Neurology, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.
  • Institute of Radioisotope Research, St. Marianna University Graduate School of Medicine, Kawasaki 216-8512, Japan.
  • Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.
  • Department of Clinical Laboratory, Subaru Health Insurance Society Ota Memorial Hospital, Ota 373-8585, Japan.

Förderung

  • Health and Labour Sciences Research Grant on Rare and Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan
  • Practical Research Project for Rare/Intractable Diseases of the Japan Agency for Medical Research and Development
  • Ministry of Health, Labour, and Welfare of Japan

Zitieren

APA

Sato, T., Yagishita, N., Araya, N., Nakashima, M., Horibe, E., Takahashi, K., Kunitomo, Y., Nawa, Y., Hamaguchi, I., & Yamano, Y. (2024). Diagnostic Value of Anti-HTLV-1-Antibody Quantification in Cerebrospinal Fluid for HTLV-1-Associated Myelopathy. Viruses. https://doi.org/10.3390/v16101581

Vancouver

Sato T, Yagishita N, Araya N, Nakashima M, Horibe E, Takahashi K, et al. Diagnostic Value of Anti-HTLV-1-Antibody Quantification in Cerebrospinal Fluid for HTLV-1-Associated Myelopathy. Viruses. 2024. doi:10.3390/v16101581

BibTeX
@article{Sato2024,
  author = {Sato, Tomoo and Yagishita, Naoko and Araya, Natsumi and Nakashima, Makoto and Horibe, Erika and Takahashi, Katsunori and Kunitomo, Yasuo and Nawa, Yukino and Hamaguchi, Isao and Yamano, Yoshihisa},
  title = {Diagnostic Value of Anti-HTLV-1-Antibody Quantification in Cerebrospinal Fluid for HTLV-1-Associated Myelopathy},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16101581}
}
Kostenlos starten →